Resource Type




Disorder / CDG Type

All CDGs


Congenital disorders of glycosylation (CDG) are a complex and heterogeneous family of rare metabolic diseases. With a clinical history that dates back over 40 years, it was the recent multi-omics advances that mainly contributed to the fast-paced and encouraging developments in the field. However, much remains to be understood, with targeted therapies' discovery and approval being the most urgent unmet need. In this paper, we present the 2022 state of the art of CDG, including glycosylation pathways, phenotypes, genotypes, inheritance patterns, biomarkers, disease models, and treatments. In light of our current knowledge, it is not always clear whether a specific disease should be classified as a CDG. This can create ambiguity among professionals leading to confusion and misguidance, consequently affecting the patients and their families. This review aims to provide the CDG community with a comprehensive overview of the recent progress made in this field.


Rita Francisco
Sandra Brasil
Joana Poejo
Jaak Jaeken
Carlota Pascoal
Paula A Videira
Vanessa Dos Reis Ferreira


Congenital Disorders of Glycosylation

View or Download

To view or download this resource you are required to be logged in.

If you have an account please Login here. If not, you can create one here.

Page modified at Monday, October 23, 2023 - 09:30